Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression

Hydrogen sulfide inhibits macrophage-derived foam cell formation

(2011) Zhan-Zhi Zhao et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo

(2010) Christina A. Bursill et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis

(2010) Wang Qiao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Regulation of cardiovascular cell function by hydrogen sulfide (H2S)

(2010) David J Elsey et al.   CELL BIOCHEMISTRY AND FUNCTION

Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases

(2010) Qihong Zhao   JOURNAL OF LEUKOCYTE BIOLOGY

Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice

(2009) Duo-Jiao Wu et al.   ATHEROSCLEROSIS

Rosiglitazone activation of PPARγ suppresses fractalkine signaling

(2009) Yihong Wan et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice

(2008) Vincent Braunersreuther et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Chemokines in Atherosclerosis

(2008) Alma Zernecke et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Role of Hydrogen Sulfide in the Development of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice

(2008) Yanfei Wang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-κB

(2008) Pankaj K. Bhavsar et al.   FASEB JOURNAL